TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

American Journal of Oral Medicine and Radiology

Volume 5, Issue 2, 2018
Mcmed International
American Journal of Oral Medicine and Radiology
Issn
XXX-XXXX (Print), 2394 - 7721 (Online)
Frequency
bi-annual
Email
editorajomr@mcmed.us
Journal Home page
Recommend to
Purchase
Abstract
Title
A PROSPECTIVE STUDY OF A SCORING SYSTEM TO ASSIST THE DECISION FOR A NEW SYSTEMIC THERAPY FOR METASTATIC MALIGNANCIES FOLLOWING AT LEAST TWO LINES OF PALLIATIVE RADIATION-THERAPY
Author
Dr. Prakash kulithungan, Dr. Revanth V
Email
Prakash@gmail.com
keyword
Metastatic malignancy, radiation therapy, cisplatin, scoring
Abstract
A provider's preference, rather than the case preference, determines how "ordinary care is provided." "Proven strategy practices are underutilized, proven unsuccessful practices are overutilized," according to the National Cancer Policy Board. Developing a scoring system to assist in the selection of a systemic therapy for metastatic tumours after two rounds of palliative radiation therapy can help. We examined all the baseline variables in an exploratory prognostic study. The prognosis was better for women, ovarian initial tumor site, and group A when analyzed univariately, but not for age, past therapy response, and the number and type of current therapy lines. Between 0% (death) and 100% are possible scores. Survival has been reasonably predicted by the score multiple times. A retrospective study using PPS evaluated the outcomes of advanced cancer patients prior to beginning a new cycle of treatment. Among the study's limitations are its few participants and the diversity of the group's original tumor types
Back to Top >>>>